{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:59:51Z","timestamp":1783025991201,"version":"3.54.6"},"reference-count":33,"publisher":"Society of Nuclear Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.2967\/jnumed.118.225250","type":"journal-article","created":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T19:55:58Z","timestamp":1556308558000},"page":"1736-1742","source":"Crossref","is-referenced-by-count":40,"title":["Radiation Dosimetry and Biodistribution of <sup>18<\/sup>F-PSMA-11 for PET Imaging of Prostate Cancer"],"prefix":"10.2967","volume":"60","author":[{"given":"Sarah","family":"Piron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathia","family":"De Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Van Laeken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"D\u2019Asseler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Bacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Kersemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet","family":"Ost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Decaestecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Deseyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Fonteyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaas","family":"Lumen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Achten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boudewijn","family":"Brans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"De Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2019,4,26]]},"reference":[{"key":"2021051712140728000_60.12.1736.1","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/ijc.29894","article-title":"Prostate cancer incidence in 43 populations worldwide: an analysis of time trends overall and by age group","volume":"138","author":"Zhou","year":"2016","journal-title":"Int J Cancer."},{"key":"2021051712140728000_60.12.1736.2","first-page":"14","article-title":"Management of biochemically recurrent prostate cancer after local therapy: evolving standards of care and new directions","volume":"11","author":"Paller","year":"2013","journal-title":"Clin Adv Hematol Oncol."},{"key":"2021051712140728000_60.12.1736.3","first-page":"S29","article-title":"The effective management of biochemical recurrence in patients with prostate cancer","volume":"7","author":"McLeod","year":"2005","journal-title":"Rev Urol."},{"key":"2021051712140728000_60.12.1736.4","doi-asserted-by":"crossref","first-page":"921674","DOI":"10.1155\/2012\/921674","article-title":"Review of salvage therapy for biochemically recurrent prostate cancer: the role of imaging and rationale for systemic salvage targeted anti-prostate-specific membrane antigen radioimmunotherapy","volume":"2012","author":"Kosuri","year":"2012","journal-title":"Adv Urol."},{"key":"2021051712140728000_60.12.1736.5","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.154153"},{"key":"2021051712140728000_60.12.1736.6","unstructured":"PSA testing for the pretreatment staging and posttreatment management of prostate cancer. American Urological Association website. http:\/\/www.auanet.org\/guidelines\/prostate-specific-antigen-(2009-amended-2013). Published 2009. Amended 2013. Accessed July 10, 2019."},{"key":"2021051712140728000_60.12.1736.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.05.053"},{"key":"2021051712140728000_60.12.1736.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(98)00278-7"},{"key":"2021051712140728000_60.12.1736.9","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-008-9104-2"},{"key":"2021051712140728000_60.12.1736.10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/carcin\/bgx141","article-title":"Prostate cancer: updates on current strategies for screening, diagnosis and clinical implications of treatment modalities","volume":"39","author":"Tian","year":"2018","journal-title":"Carcinogenesis."},{"key":"2021051712140728000_60.12.1736.11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.197160"},{"key":"2021051712140728000_60.12.1736.12","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1007\/s00259-018-4058-4","article-title":"Prospective comparison of 68Ga-PSMA PET\/CT, 18F-sodium fluoride PET\/CT and diffusion weighted-MRI at for the detection of bone metastases in biochemically recurrent prostate cancer","volume":"45","author":"Zacho","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712140728000_60.12.1736.13","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","article-title":"EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"71","author":"Mottet","year":"2017","journal-title":"Eur Urol."},{"key":"2021051712140728000_60.12.1736.14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.apradiso.2018.01.006","article-title":"Automated radiosynthesis of Al[18F]PSMA-11 for large scale routine use","volume":"135","author":"Kersemans","year":"2018","journal-title":"Appl Radiat Isot."},{"key":"2021051712140728000_60.12.1736.15","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.190157"},{"key":"2021051712140728000_60.12.1736.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2012.06.034"},{"key":"2021051712140728000_60.12.1736.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.154336"},{"key":"2021051712140728000_60.12.1736.18","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-015-0850-8"},{"key":"2021051712140728000_60.12.1736.19","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.181768"},{"key":"2021051712140728000_60.12.1736.20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s11307-015-0844-6","article-title":"Radiofluorination of PSMA-HBED via Al18F2+ chelation and biological evaluations in vitro","volume":"17","author":"Malik","year":"2015","journal-title":"Mol Imaging Biol."},{"key":"2021051712140728000_60.12.1736.21","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1007\/s00259-016-3437-y","article-title":"Synthesis and preclinical evaluation of an Al 18 F radiofluorinated GLU-UREA-LYS (AHX)-HBED-CC PSMA ligand","volume":"43","author":"Boschi","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712140728000_60.12.1736.22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41181-018-0039-y","article-title":"Synthesis of an Al18F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand in an automated synthesis platform","volume":"3","author":"Giglio","year":"2018","journal-title":"EJNMMI Radiopharm Chem."},{"key":"2021051712140728000_60.12.1736.23","doi-asserted-by":"publisher","DOI":"10.1109\/TMI.2003.812251"},{"key":"2021051712140728000_60.12.1736.24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13550-017-0339-3","article-title":"IDAC-Dose 2.1, an internal dosimetry program for diagnostic nuclear medicine based on the ICRP adult reference voxel phantoms","volume":"7","author":"Andersson","year":"2017","journal-title":"EJNMMI Res."},{"key":"2021051712140728000_60.12.1736.25","unstructured":"ICRP publication 103: the 2007 recommendations of the International Commission on Radiological Protection. ICRP website. http:\/\/www.icrp.org\/publication.asp?id=ICRP%20Publication%20103. Published 2007. Accessed July 10, 2019."},{"key":"2021051712140728000_60.12.1736.26","first-page":"423","article-title":"Total blood volume of Asian patients undergoing cardiac surgery is far from that predicted by conventional methods","volume":"54","author":"Jia","year":"2013","journal-title":"J Cardiovasc Surg (Torino)."},{"key":"2021051712140728000_60.12.1736.27","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-1770"},{"key":"2021051712140728000_60.12.1736.28","unstructured":"Halma C . The serum creatinine level as a measure of renal function [in Dutch]. Dutch Journal of Medicine website. https:\/\/www.ntvg.nl\/artikelen\/het-serumcreatininegehalte-als-maat-voor-de-nierfunctie\/volledig. Published August 5, 1990. Accessed July 10, 2019."},{"key":"2021051712140728000_60.12.1736.29","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-016-3419-0"},{"key":"2021051712140728000_60.12.1736.30","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00259-016-3573-4","article-title":"F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients","volume":"44","author":"Giesel","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712140728000_60.12.1736.31","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1007\/s00259-016-3424-3","article-title":"Biodistribution and radiation dosimetry of 68Ga-PSMA HBED CC\u2014a PSMA specific probe for PET imaging of prostate cancer","volume":"43","author":"Pfob","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712140728000_60.12.1736.32","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.104661"},{"key":"2021051712140728000_60.12.1736.33","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.161299"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.118.225250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:45:52Z","timestamp":1621284352000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.118.225250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,26]]},"references-count":33,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12,2]]},"published-print":{"date-parts":[[2019,12]]}},"alternative-id":["10.2967\/jnumed.118.225250"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.118.225250","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,26]]}}}